$KEQU

Gardner Donald T. III sold (to issuer) $435K of KEQU

Gardner Donald T. III (Chief Financial Officer) sold (to issuer) 12,000 shares of KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) at $36.25 ($0.44M total) on 2026-06-30.

Original reporting
SEC EDGAR · Gardner Donald T. III
Published Jul 2, 2026, 3:49 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 3:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$KEQU
Neutral
medium confidence
Mentioned
$KEQU
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KEQUNeutralLow
01

Why it matters

The filing updates insider ownership (18,829 shares after sale) and may slightly influence sentiment, but it does not introduce new company-specific fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but the disclosure alone is unlikely to drive a material repricing without accompanying fundamental news.

03

What to watch

No 10b5-1 plan is indicated, but the filing still lacks context (tax, diversification, planned liquidity) and does not quantify any broader insider selling trend.

Relevance 4/10Novelty 3/10Timing: Form 4 filed 2026-07-02 (transaction dated 2026-06-30)

Background

This is an SEC Form 4 insider transaction disclosure for KEQU, reported by the CFO.

Company-level read

Ticker impact

$KEQUNeutralMedium confidence
Context

KEQU CFO Donald T. Gardner III sold 12,000 shares to the issuer at $36.25 on 2026-06-30, per Form 4 filed 2026-07-02.

Expected impact

Likely limited/short-lived impact; any effect would be sentiment-driven and small versus normal insider-flow noise.

Evidence & confidence

Form 4 discloses transaction size ($435k) and role (CFO) but provides no new operating, guidance, or deal information; insider sales often have non-informational motives.

Market effects

No sector read-across; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

The sale is coded as “sale to issuer,” which commonly aligns with buyback participation or liquidity mechanics rather than bearish information.

Key entities

  • KEQU

    Kewaunee Scientific Corp /DE/; subject of the Form 4 insider sale to issuer.

  • Donald T. Gardner III

    Chief Financial Officer; sold 12,000 shares to the issuer at $36.25 on 2026-06-30.

Related articles

$KEQUMed

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU): Results of Operations and Financial Condition

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 prfy26q4earningsrelease.htm EX-99.1 Document Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. June 23, 2026 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ